Arturo Molina - Jan 16, 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Medical Officer
Signature
/s/ Asif Ali, Attorney-in-Fact for Arturo Molina, MD
Stock symbol
PTGX
Transactions as of
Jan 16, 2023
Transactions value $
$0
Form type
4
Date filed
1/18/2023, 06:51 PM
Previous filing
Nov 17, 2022
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Award $0 +3.13K +14.71% $0.00 24.4K Jan 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +18.8K $0.00 18.8K Jan 16, 2023 Common Stock 18.8K $12.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026.
F2 The stock option vests in 48 equal monthly installments following the date of grant.